Revolution Medicines Share Price Today
(NASDAQ: RVMD)

Name: Revolution Medicines Share Price Today (NASDAQ: RVMD) - Revolution Medicines Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Revolution Medicines share price is $36.76 & ₹3,141.69 as on 18 Apr 2025, 2.30 'hrs' IST

$36.76

▲

0.56

(1.55%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Revolution Medicines share price in Dollar and Rupees. Guide to invest in Revolution Medicines stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Revolution Medicines, along with analyst recommendations, forecasts, and comprehensive financials.

Revolution Medicines share price movements

Today's Low: $35.85
Today's High: $36.84
$36.76
2.49%
Downside
Day's Volatility :2.7%
Upside
0.22%
52 Weeks Low: $29.17
52 Weeks High: $62.40
$36.76
20.65%
Downside
52 Weeks Volatility :53.25%
Upside
41.09%

Revolution Medicines (RVMD) Returns

Period	Revolution Medicines Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.47%	-3.3%	0.0%
6 Months	-23.02%	-11.5%	0.0%
1 Year	0.91%	-2.5%	0.0%
3 Years	68.78%	-2.1%	-12.9%

Revolution Medicines (RVMD) Key Statistics

in dollars & INR

Previous Close	$36.2
Open	$36.06
Today's High	$36.84
Today's Low	$35.845
Market Capitalization	$6.8B
Today's Volume	$1.3M
52 Week High	$62.4
52 Week Low	$29.17
Revenue TTM	$742.0K
EBITDA	$-683.0M
Earnings Per Share (EPS)	$-3.58
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-29.33%

How to invest in Revolution Medicines Stock (RVMD) from India?

It is very easy for Indian residents to invest directly in Revolution Medicines from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Revolution Medicines stock in both Indian Rupees (INR) and US Dollars (USD). Search for Revolution Medicines or RVMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Revolution Medicines or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Revolution Medicines shares which would translate to 0.023 fractional shares of Revolution Medicines as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Revolution Medicines, in just a few clicks!

Returns in Revolution Medicines (RVMD) for Indian investors in Rupees

The Revolution Medicines stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Revolution Medicines investment value today

Current value as on today

₹1,07,610

Returns

₹7,610

(+7.61%)

Returns from Revolution Medicines Stock

₹5,269 (+5.27%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Revolution Medicines (RVMD)

260%

Period: Mar 20, 2025 to Apr 19, 2025. Change in 30 Days versus previous period

Search interest for Revolution Medicines Stock from India on INDmoney has increased by 260% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Revolution Medicines

Vanguard Group Inc
9.20%
BlackRock Inc
7.92%
Farallon Capital Management, L.L.C.
7.13%
Wellington Management Company LLP
5.82%
HHG PLC
5.10%
Baker Bros Advisors LP
4.27%

Analyst Recommendation on Revolution Medicines

Rating

Trend

Buy

94%Buy

5%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Revolution Medicines(by analysts ranked 0 to 5 stars)

Analyst Forecast on Revolution Medicines Stock (RVMD)

What analysts predicted

Upside of 96.77%

Target:

$72.33

Current:

$36.76

Insights on Revolution Medicines Stock (Ticker Symbol: RVMD)

Price Movement
In the last 3 years, RVMD stock has moved up by 53.6%
Decreasing Revenue
Revenue is down for the last 4 quarters, 15.33M → 742.0K (in $), with an average decrease of 60.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -116.00M → -194.56M (in $), with an average decrease of 18.9% per quarter
RVMD vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 78.3% return, outperforming this stock by 73.0%
Price to Sales
ForRVMD every $1 of sales, investors are willing to pay $7352.0, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Revolution Medicines Technicals Summary

Sell

Neutral

Buy

Revolution Medicines is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Revolution Medicines (RVMD) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Revolution Medicines Inc	-4.49%	-23.02%	0.91%	68.78%	43.09%
Regeneron Pharmaceuticals, Inc.	-15.01%	-41.85%	-37.44%	-20.24%	3.43%
Beone Medicines Ltd	-12.04%	5.03%	76.4%	40.23%	45.7%
Vertex Pharmaceuticals Incorporated	-4.13%	2.3%	22.3%	73.62%	86.11%
Alnylam Pharmaceuticals, Inc.	-7.49%	-19.67%	60.89%	39.0%	70.16%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Revolution Medicines Inc	NA	NA	NA	-4.48	-0.29	-0.19	NA	12.19
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Revolution Medicines Inc	Buy	$6.8B	43.09%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	3.43%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	45.7%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	86.11%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	70.16%	NA	-12.37%

Revolution Medicines Dividend announcements

Revolution Medicines Earnings
Revolution Medicines’s price-to-earnings ratio stands at None

About Revolution Medicines

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Organization	Revolution Medicines
Employees	534
CEO	Dr. Mark A. Goldsmith Ph.D.
Industry	Health Technology

Management People of Revolution Medicines

Name	Title
Dr. Mark A. Goldsmith Ph.D.	CEO, President & Chairman
Mr. Jack Anders	Chief Financial Officer
Ms. Margaret A. Horn J.D.	Chief Operating Officer
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.	President of Research & Development
Ms. Xiaolin Wang	Executive Vice President of Development
Dr. Martin D. Burke M.D., Ph.D.	Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael A. Fischbach Ph.D.	Academic Co-Founder & Member of Scientific Advisory Board
Dr. Kevan M. Shokat Ph.D.	Academic Co-Founder & Member of Scientific Advisory Board
Mr. Walter Reiher Ph.D.	Chief Information Officer
Ms. Jan Smith Ph.D.	Chief Scientific Officer

Important FAQs about investing in RVMD Stock from India :

What is Revolution Medicines share price today?

Revolution Medicines share price today stands at $36.76, Open: $36.06 ; Previous Close: $36.20 ; High: $36.84 ; Low: $35.85 ; 52 Week High: $62.40 ; 52 Week Low: $29.17.

The stock opens at $36.06, after a previous close of $36.20. The stock reached a daily high of $36.84 and a low of $35.85, with a 52-week high of $62.40 and a 52-week low of $29.17.

Can Indians buy Revolution Medicines shares?

Yes, Indians can invest in the Revolution Medicines (RVMD) from India.

With INDmoney, you can buy Revolution Medicines at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Revolution Medicines at zero transaction cost.

How can I buy Revolution Medicines shares from India?

It is very easy to buy Revolution Medicines from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Revolution Medicines (RVMD) be purchased?

Yes, you can buy fractional shares of Revolution Medicines with INDmoney app.

What are the documents required to start investing in Revolution Medicines stocks?

To start investing in Revolution Medicines, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.